Search

everythinglearnresearchcommunity

for

Search:↓

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Elagolix did not effectively treat polycystic ovary syndrome.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Cynatine HNS improves hair and nail quality in 90 days.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Phage therapy could be a safe and effective new treatment for acne.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

A spermidine-based supplement may help hair grow longer by keeping it in the growth phase.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

India is ideal for dermatology trials due to diverse patients and cost-effectiveness.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Using platelet-rich plasma, basic fibroblast growth factor, and minoxidil together significantly increases hair count and growth rate in people with hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.